Peritonsillar abscess. Our experience in 5 years

Authors

  • Maira Verena Guerrero Aguilar Hospital Universitario Carlos M. de Céspedes. Bayamo. Granma
  • Luis Augusto Pompa Milanés Hospital Universitario Carlos M. de Céspedes. Bayamo. Granma
  • Lidia Rosa Cutiño Montero Hospital Universitario Carlos M. de Céspedes. Bayamo. Granma

Keywords:

peritonsillar abscess, clinical diagnosis, signs and symptoms, anti-bacterial agents.

Abstract

A retrospective observational descriptive study was conducted with review of the medical records of admitted patients with the diagnosis of peritonsillar abscess in the Carlos M. de Cespedes Hospital of Bayamo, from January 1, 2012 to December 31, 2016 with a total of 52 patients out of 55, excluding 3 patients due to one presenting a Ludwig's angina and two patients with an abscess of the last molar. The following variables are investigated: age, sex, origin, symptoms and signs, variety of the abscess, surgical procedure, hospital stay and treatment, obtaining the following results: the average age was 35.4 years, the main symptoms and signs were odynophagia, fever and bulging of pillars, the left anterior variety predominated, the longest interval of stay was 1 to 5 days and the antibiotic most frequently used was penicillin.

Downloads

Download data is not yet available.

References

1. Manzoni Seering M, Chueiri L, Jacques J, Picoli CMMF, Batista CSM, Buffon Ztt D, et al. Bilateral peritonsillar abscess in an infant: an unusual presentation of sore throat. Case Rep Otolaryngol [Internet]. 2017 [citado 14 Mar 2017]; 4670152. Disponible en: http://www.hindawi.com/journals/criot/2017/4670152.

2. Tsai YW, Liu YH, Su HH. Bacteriology of peritonsillar abscess: the changing trend and predisposing factors. Br J Otorrhinolaryngol (BJORL) [Internet]. 2017; [20 Feb 2017]; 552. Disponible en: https://ac.els-cdn.com/S1808869417301076/1-s2.0-S1808869417301076-main.pdf?_tid=515a11a2-0a9d-11e8-89b5-00000aab0f27&acdnat=1517853322_027ec6a09ed4da26440b6280bb7ffc94.

3. Feasson T, Debeaupte M, Bidet C, Ader F, Disart F, Ferry T, et al. Impact of anti-inflammatory drug consumption in peritonsillar abscess: a retrospective cohort study. BMC Infect Dis [Internet]. 2016 [citado 14 Mar 2017]; 16:432. Disponible en: http://www.biomedcentral.com/track/pdf/10.1186/S12879-016-1761-2?site=bmcinfectdis.biomedcentral.com.

4. AlAwadh I, Aldrees T, AlQaryan S, Alharethy S, AlShehri H. Bilateral peritonsillar abscess: A case report and pertinent literature review. Int J Surg Case Rep [Internet]. 2017 [citado 14 Mar 2017]; 36:34-7. Disponible en: http://www.casereports.com/articl/S2210-2612(17)30214-6/pdf.

5. Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Assery N, Ballereau F, et al. Peritonsillar abscess (PTA): Clinical characteristics, microbiology, drug exposures and outcomes of a large multicentre cohort survey of 412 patients hospitalized in 13 French university hospitals. Eur J Clin Microbiol Infect Dis. 2016; 35: 867-73.

6. Wiksten J, Blomgren K, Eriksson T, Guldfred L, Bratt M, Pitkäranta A. Variations in treatment of peritonsillar abscess in four Nordic countries. Acta Otolaryngol. 2014; 134(8):813-7.

7. Tachibana T, Orita Y, Abe Fujisawa I, Ogawara Y, Matsuyama Y, Shimizu A, et al. Prognostic factors and effects of early surgical drainge in patients with peritonsillar abscess. J Infect Chemother Off J Jpn Soc Chemother. 2014; 20(11):722-5.

8. Kim DK, Lee JW, Na YS, Kim MJ, Lee JH, Park CH. Clinical factor for successful nonsurgical treatment of pediatric peritonsillar abscess. Laryngoscope. 2015; 125(11):2608-11.

9. Shaul C, Koslowsky B, Rodríguez M, Schearz Y, Muahnna N, Peleg U, et al. Is needle aspiration for peritonsillar abscess still as god as we think? A long-term follow-up. Ann Otol Rhinol Laryngol. 2014. Doi: 10.1177/000348944556083.

10. Klug TE. Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender. Eur J Microbiol Infect Dis. 2014; 33:1163-7.

11. Mazur E, Czerwinska E, Korona Glowniak I, Grochowalska A, Koziol Montewka M. Epidemiology, clinical history and microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2015; 34:549-54.

12. Windfuhr JP, Zurawski A. Peritonsillar abscess: remember always think twice. Eur Arch Otorrhinolaryngol. 2016; 273:1269-81.

13. Sowerby LJ, Hussain Z, Husein M. The epidemiology, antibiotic resistance and post-discharge course of peritonsillar abscesses in London, Ontario. J Otolaryn Head Neck Surg [Internet]. 2013 [citado 24 Mar 2017]; 42(5). Disponible en: http://www.journalotohns/content/42/1/5.

14. Wang YP, Wang MC, Lin HC, Chou P. The impact of prior tonsillitis and treatment modality on the recurrence of peritonsillar abscess: A nationwide cohort study. PLoS ONE [Internet]. 2014 [citado 22 Mar 2017]; 9(10): e109887. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188615/pdf/pone.0109887.pdf.

Published

2018-03-02

How to Cite

1.
Guerrero Aguilar MV, Pompa Milanés LA, Cutiño Montero LR. Peritonsillar abscess. Our experience in 5 years. RM [Internet]. 2018 Mar. 2 [cited 2025 Jun. 2];22(1):1-11. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/773

Issue

Section

ARTÍCULOS ORIGINALES